JVMSX | |
Total Expense Ratio | 1.25 |
Annual Report Gross Expense Ratio | 1.26 |
Fund Existence | 13 years |
Gain YTD | -2.424 |
Front Load | N/A |
Min. Initial Investment | 0 |
Min. Initial Investment IRA | N/A |
Net Assets | 20.6B |
Annual Yield % from dividends | 0.46 |
Returns for 1 year | -8.45 |
Returns for 3 years | 4.66 |
Returns for 5 years | 50.94 |
Returns for 10 years | 27.80 |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XBI | 78.04 | 0.69 | +0.89% |
SPDR® S&P Biotech ETF | |||
XBAP | 35.08 | 0.15 | +0.44% |
Innovator US Eq Acltd 9 Bfr ETFTM April | |||
MARW | 31.14 | 0.11 | +0.34% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
DFSI | 37.11 | -0.01 | -0.02% |
Dimensional International Sstby Cr 1 ETF | |||
BFIX | 25.14 | -0.08 | -0.30% |
Build Bond Innovation ETF |